Developing an immune signature for triple-negative breast cancer to predict prognosis and immune checkpoint inhibitor response.
Future Oncol
; 18(9): 1055-1066, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-35105171
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Prognosis
/
Gene Expression Regulation, Neoplastic
/
Triple Negative Breast Neoplasms
/
Immune Checkpoint Inhibitors
Type of study:
Evaluation_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Year:
2022
Type:
Article